Pure Fish Oil Parenteral Lipid Emulsion in Patients With Gastrointestinal Cancer
Surgery
About this trial
This is an interventional treatment trial for Surgery focused on measuring Fish oil, Omega-3 fatty acids, Parenteral lipid emulsions, Immune response, Surgery
Eligibility Criteria
Inclusion Criteria:
Elective surgical patients with confirmed (biopsy) gastrointestinal (colon or stomach) cancer; 30-75 years old; venous assess to blood collections (40 mL) to receive parenteral infusions of lipid emulsion; Karnofsky performance statuses of ≥60
Exclusion Criteria:
Intolerance or allergy to any ingredient in lipid emulsion; diagnosis of infectious, inflammatory, immunologic or metabolic diseases; dementia;medicine intake that could significantly modulate metabolism; implanted electromagnetic instruments.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Fish oil lipid emulsion
MCT/LCT lipid emulsion
Parenteral lipid emulsion composed by fish oil which is rich in the omega-3 polyunsaturated fatty acids eicosapentanoic and docosahexanoic.
Parenteral lipid emulsion containing 50% of medium-chain triglycerides and 50% of soybean oil